Imperial College London

Jiri Pavlu

Faculty of MedicineDepartment of Immunology and Inflammation

Honorary Clinical Senior Lecturer



+44 (0)20 3313 8117j.pavlu Website




Leuka Building R2.20Hammersmith HospitalHammersmith Campus





Jiri Pavlu is a Consultant Haematologist at Hammersmith Hospital and Honorary Clinical Senior Lecturer at Imperial College London. He graduated from the First Faculty of Medicine of Charles University in Prague in 1998. In completing this he was part of the research group of Professor Gordon-Smith at St.Georges Hospital Medical School in London and obtained his research degree in molecular haematology. He completed his specialist haematology training in London on the Royal Free and Hammersmith rotation.

He has developed a specialist interest in haematopoietic stem cell transplantation, particularly for leukaemia. He is the clinical lead for acute leukaemia and myelodysplastic syndromes and a stem cell transplant clinical and collection facility director. Together with Gill Brisley, clinical nurse specialist, and the transplant coordinators he runs relevant specialist haematology clinics at Hammersmith Hospital. He is a principal investigator and subinvestigator of various clinical trials, an active member of the European Group for Blood and Marrow Transplantation (EBMT) Acute leukaemia working party and also an accredited inspector for the Joint Accreditation Committee – International Society for Cellular Therapy (Europe) & EBMT.

Secretary: +44 (0) 2083838117, +44 (0) 2083835030
Fax: +44 (0) 2033133965



Craddock C, Jackson A, Loke J, et al., 2020, Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia., J Clin Oncol

Ghani R, Mullish BH, McDonald JAK, et al., 2020, Disease prevention not decolonization – a model for fecal microbiota transplantation in patients colonized with multidrug-resistant organisms, Clinical Infectious Diseases, ISSN:1058-4838

Nagler A, Dholaria B, Labopin M, et al., 2020, Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia, Leukemia, Vol:34, ISSN:0887-6924, Pages:2766-2775


Innes AJ, Ghani R, Mullish BH, et al., 2020, O105. Faecal microbiota transplant (FMT) can reduce the high NRM associated with multi-drug resistant organism (MDRO) colonisation prior to allogeneic HCT., The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation, Springer Nature [academic journals on], Pages:122-122, ISSN:0268-3369

Penack O, Peczynski C, van der Werf S, et al., 2020, Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party, 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), FERRATA STORTI FOUNDATION, Pages:1977-1983, ISSN:0390-6078

More Publications